• The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
  • Subscribe
  • Sign in
  • Pharma
  • Medtech
  • Biotech
  • Science
  • Events
  • Careers
  • Jobs
  • Opinion & Debate
  • The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
Menu
  • Subscribe
  • Sign in

No 02 2019

QTE Development

-

May 1, 2019

Share article on X
Share article on Linkedin

Updated: January 31, 2025, 09:23 am

Published: May 1, 2019

Top stories

Funding – April 29, 2026

Ulf Landegren and his family create research foundation

Through a donation, a new foundation has been formed called Familjen Landegrens stiftelse för medicinsk forskning (Landegren Family Foundation for Medical Research). The purpose of this foundation is to support Uppsala University’s medical research and medical innovation.

Sweden – April 29, 2026

Stockholm Science City’s Ylva Williams sees a more integrated life science region emerging

Once a fragmented landscape of strong research but limited cohesion, Stockholm’s life science ecosystem is now accelerating toward a more integrated future – a shift that Stockholm Science City’s CEO Ylva Williams has helped drive over nearly two decades.

Uncategorized – April 29, 2026

Tortugas Neuroscience launches with USD 106 million for mid‑stage brain drugs

The US‑based company has debuted in combined seed and Series A financing to advance a portfolio of mid‑stage neurology and neuropsychiatry drugs in‑licensed from Eisai and Hansoh.

Financing – April 28, 2026

Ray Therapeutics raises USD 125 million, Novo Holdings doubles down on optogenetic eye gene therapy

The US company has closed an upsized, oversubscribed Series B to advance its optogenetic gene therapy pipeline for blinding retinal diseases with Novo Holdings reinforcing a strong Nordic investment footprint in late‑stage ophthalmology.

Follow NLS news
Follow us on XFollow us on LinkedinFollow us on Bluesky

Related posts

Funding - April 29, 2026

Ulf Landegren and his family create research foundation

Through a donation, a new foundation has been formed called Familjen Landegrens stiftelse för medicinsk forskning (Landegren Family Foundation for Medical Research). The purpose of this foundation is to support Uppsala University’s medical research and medical innovation.

Sweden - April 29, 2026

Stockholm Science City’s Ylva Williams sees a more integrated life science region emerging

Once a fragmented landscape of strong research but limited cohesion, Stockholm’s life science ecosystem is now accelerating toward a more integrated future – a shift that Stockholm Science City’s CEO Ylva Williams has helped drive over nearly two decades.

Uncategorized - April 29, 2026

Tortugas Neuroscience launches with USD 106 million for mid‑stage brain drugs

The US‑based company has debuted in combined seed and Series A financing to advance a portfolio of mid‑stage neurology and neuropsychiatry drugs in‑licensed from Eisai and Hansoh.

Financing - April 28, 2026

Ray Therapeutics raises USD 125 million, Novo Holdings doubles down on optogenetic eye gene therapy

The US company has closed an upsized, oversubscribed Series B to advance its optogenetic gene therapy pipeline for blinding retinal diseases with Novo Holdings reinforcing a strong Nordic investment footprint in late‑stage ophthalmology.

Pharma Business - April 27, 2026

AstraZeneca’s Saphnelo receives US approval

Saphnelo (anifrolumab) has been approved in the US for self-administration as a once-weekly autoinjector, the Saphnelo Pen, for the treatment of adult patients with systemic lupus erythematosus (SLE) on top of standard therapy.

Business Award - April 27, 2026

SerendoTx wins AbbVie Scandinavia Golden Ticket 2026

Serendo Therapeutics (SerendoTx) has been named the winner of the AbbVie Scandinavia Golden Ticket 2026, awarded in collaboration with Karolinska Institutet Innovation.

Acquisition - April 27, 2026

AddLife acquires CoaChrom Diagnostica

AddLife has acquired CoaChrom Diagnostica, an Austrian niche company specializing in advanced coagulation diagnostics.

Sign up to our Newsletter!

I confirm that I want to subscribe to newsletters from Nordic Life Science and that Nordic Life Science has the right to save my email address. Read our privacy policy here

Read the latest issue!

Sign up for a subscription and read our latest digital issue today.

Sign up
Sign up

The leading life science news channel in the Nordic region.

© NLS Media Group AB – All rights reserved

Digital and print
  • The magazine
  • Subscribe
  • Newsletter
More information
  • About us
  • Contact
  • Advertising
Social media
  • LinkedIn
  • Bluesky
  • X
NLS Media Group AB

St Paulsgatan 13

118 46 Sweden

info@nlsnews.com

+46-8-588 941 51

  • Cookies
  • Data management and privacy policy

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.